Role of peripheral sensory neuron mu-opioid receptors in nociceptive, inflammatory, and neuropathic pain

Neuropathic PainPain Management

Nerve injury-induced epigenetic silencing of opioid receptors controlled by DNMT3a in primary afferent neurons

Pain.

Sun L, Zhao JY, Gu X, Liang L, Wu S, Mo K, Feng J, Guo W, Zhang J, Bekker A, Zhao X, Nestler EJ, Tao YX

doi: 10.1097/j.pain.

Neuropathic Pain

SIGMA-1 receptor gene variants affect the somatosensory phenotype in neuropathic pain patients

J Pain.

Sachau J, Bruckmueller H, Gierthmühlen J, Magerl W, Kaehler M, Haenisch S, Binder A, Caliebe A, Maier C, Treede RD, Tölle T, Cascorbi I, Baron R

doi: 10.1016/j.jpain.2018.08.011.

Neuropathic Pain

The role of cyclin dependent kinase 5 (Cdk5) in neuropathic pain

Pain.

Gomez K, Vallecillo TGM, Moutal A, Perez-Miller S, Delgado-Lezama R, Felix R, Khanna R

doi: 10.1097/j.pain.

Neuropathic Pain

Regulatory T cells counteract neuropathic pain through inhibition of the Th1 response at the site of peripheral nerve injury

Pain.

Davoli-Ferreira M, de Lima KA, Fonseca MM, Guimarães RM, Gomes FI, Cavallini MC, Quadros AU, Kusuda R, Cunha FQ, Alves-Filho JC, Cunha TM

doi: 10.1097/j.pain.0000000000001879.

RECOMMENDED

Neuropathic Pain

AAPT Diagnostic Criteria for Peripheral Neuropathic Pain: Focal and Segmental Disorders

J Pain.

Freeman R, Edwards R, Baron R, Bruehl S, Cruccu G, Dworkin RH, Haroutounian S

doi: 10.1016/j.jpain.2018.10.002.

Neuropathic Pain

Bifunctional peptide-based opioid agonist/nociceptin antagonist ligand for dual treatment of nociceptive and neuropathic pain

Pain.

Lagard C, Chevillard L, Guillemyn K, Risède P, Laplanche JL, Spetea M, Ballet S, Mégarbane B

doi: 10.1097/

Acute PainChronic Pain

Peripheral Opioid Receptor Antagonists for Opioid-Induced Constipation: A Primer on Pharmacokinetic Variabilities with a Focus on Drug Interactions

J Pain Res.

Gudin J, Fudin J

doi: 10.2147/JPR.S220859.

COMMENTED

Chronic Pain

Chronic pain in breast cancer survivors: nociceptive, neuropathic or central sensitization pain?

Pain Pract.

Leysen L, Adriaenssens N, Nijs J, Pas R, Bilterys T, Vermeir S, Lahousse A, Beckwée D

doi: 10.1111/papr.12732.

Back Pain

Summit-07: A randomized trial of NKTR-181, a new molecular entity, full mu-opioid receptor agonist for chronic low-back pain

Pain.

Markman J, Gudin J, Rauck R, Argoff C, Rowbotham M, Agaiby E, Gimbel J, Katz N, Doberstein SK, Tagliaferri M, Lu L, Siddhanti S, Hale M

doi: 10.1097/

Related content

Nerve injury-induced epigenetic silencing of opioid receptors controlled by DNMT3a in primary afferent neurons

SIGMA-1 receptor gene variants affect the somatosensory phenotype in neuropathic pain patients

The role of cyclin dependent kinase 5 (Cdk5) in neuropathic pain

Regulatory T cells counteract neuropathic pain through inhibition of the Th1 response at the site of peripheral nerve injury

AAPT Diagnostic Criteria for Peripheral Neuropathic Pain: Focal and Segmental Disorders

Bifunctional peptide-based opioid agonist/nociceptin antagonist ligand for dual treatment of nociceptive and neuropathic pain

Peripheral Opioid Receptor Antagonists for Opioid-Induced Constipation: A Primer on Pharmacokinetic Variabilities with a Focus on Drug Interactions

Chronic pain in breast cancer survivors: nociceptive, neuropathic or central sensitization pain?

Summit-07: A randomized trial of NKTR-181, a new molecular entity, full mu-opioid receptor agonist for chronic low-back pain